Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer
352.5500 4.20 (1.21%)
NSE Sep 01, 2025 15:31 PM
Volume: 1.6M
 

announcement
Conference/Earnings Calls Alerts
logo
Biocon Ltd.
17 Sep 2021
352.55
1.21%

Conference Call with Management from Biocon (Kiran Mazumdar Shaw) and Serum Institute (Adar Poonawalla) on the strategic alliance between Biocon Biologics and Serum Institute subsidiary Covidshield Technologies. Listen to the full transcript.

More from Biocon Ltd.
Recommended